First Foundation Advisors Abbott Laboratories Transaction History

First Foundation Advisors

  • $2.58 Billion
  • Q3 2024

A detailed history of First Foundation Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, First Foundation Advisors holds 10,706 shares of ABT stock, worth $1.21 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,706
Previous 11,141 3.9%
Holding current value
$1.21 Million
Previous $1.16 Million 5.45%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $43,530 - $51,386
-435 Reduced 3.9%
10,706 $1.22 Million
Q2 2024

Aug 06, 2024
SELL
$100.73 - $112.44 $31,427 - $35,081
-312 Reduced 2.72%
11,141 $1.16 Million
Q1 2024

May 09, 2024
SELL
$109.52 - $120.96 $42,384 - $46,811
-387 Reduced 3.27%
11,453 $1.3 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $636,651 - $779,313
-7,059 Reduced 37.35%
11,840 $1.3 Million
Q3 2023

Nov 15, 2023
BUY
$95.53 - $114.62 $189,627 - $227,520
1,985 Added 11.74%
18,899 $1.83 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $364,118 - $405,703
3,613 Added 27.16%
16,914 $1.84 Million
Q1 2023

May 12, 2023
BUY
$96.86 - $114.01 $2,712 - $3,192
28 Added 0.21%
13,301 $1.35 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $1,520 - $1,784
-16 Reduced 0.12%
13,273 $1.46 Million
Q3 2022

Nov 10, 2022
BUY
$96.76 - $112.03 $23,996 - $27,783
248 Added 1.9%
13,289 $1.29 Million
Q2 2022

Aug 12, 2022
SELL
$102.07 - $123.37 $12,962 - $15,667
-127 Reduced 0.96%
13,041 $1.42 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $195,430 - $238,314
1,714 Added 14.96%
13,168 $1.56 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $20,679 - $25,321
179 Added 1.59%
11,454 $1.61 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $26,715 - $29,554
229 Added 2.07%
11,275 $1.33 Million
Q2 2021

Aug 13, 2021
BUY
$105.79 - $124.53 $1.17 Million - $1.38 Million
11,046 New
11,046 $1.28 Million
Q1 2021

May 18, 2021
SELL
$108.84 - $128.23 $1.18 Million - $1.39 Million
-10,814 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $60,270 - $65,677
-574 Reduced 5.04%
10,814 $1.18 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $118,857 - $144,343
1,297 Added 12.85%
11,388 $1.24 Million
Q2 2020

Aug 14, 2020
BUY
$76.57 - $98.0 $147,473 - $188,748
1,926 Added 23.59%
10,091 $923,000
Q1 2020

May 11, 2020
BUY
$62.82 - $91.86 $13,631 - $19,933
217 Added 2.73%
8,165 $644,000
Q4 2019

Feb 11, 2020
BUY
$78.51 - $87.4 $79,138 - $88,099
1,008 Added 14.52%
7,948 $690,000
Q3 2019

Nov 12, 2019
BUY
$81.84 - $88.74 $22,915 - $24,847
280 Added 4.2%
6,940 $581,000
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $56,919 - $66,385
781 Added 13.28%
6,660 $560,000
Q1 2019

May 13, 2019
BUY
$66.22 - $80.06 $8,277 - $10,007
125 Added 2.17%
5,879 $470,000
Q4 2018

Feb 14, 2019
SELL
$65.56 - $74.27 $8,195 - $9,283
-125 Reduced 2.13%
5,754 $416,000
Q3 2018

Nov 13, 2018
SELL
$60.81 - $73.36 $12,709 - $15,332
-209 Reduced 3.43%
5,879 $431,000
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $1,554 - $1,715
27 Added 0.45%
6,088 $371,000
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $207,467 - $234,566
-3,687 Reduced 37.82%
6,061 $363,000
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $21,472 - $22,988
-400 Reduced 3.94%
9,748 $556,000
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $11,342 - $12,659
236 Added 2.38%
10,148 $541,000
Q2 2017

Aug 14, 2017
BUY
N/A
9,912
9,912 $482,000

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email